A regenerative medicine company will open a headquarters office in Boca that includes manufacturing and distribution ...

Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...

XREVIV represents a new frontier in personalized health optimization, integrating genetic science, blood biomarker analysis, ...

Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...

Although rare kidney diseases remain a significantly overlooked contributor to the global burden of CKD, things have begun to ...

Life Sciences Investors offers a 10.1% yield, diversified healthcare exposure, and trades at a NAV discount. Learn why HQL ...

Pfizer and Novo Nordisk are in a takeover clash over the obesity biotech Metsera, while some House Republicans warm to ...

Pfizer plans to sweeten its bid for Metsera , a person familiar with the matter told Reuters, after a judge denied its ...

Tom Brady just announced that his new dog Junie is a clone of his late dog Lua. He isn't the first celebrity to do that.

Boutique PR agency recognized for driving credibility and growth across high-impact sectors, including biotechnology, fintech, blockchain, and advanced energy ...

Ultragenyx Pharmaceutical (RARE) remains unprofitable, with net losses expanding at an average annual rate of 14.8% over the past five years. Even as the company’s profit margin has yet to turn ...

Speculative activity surged across the micro-cap landscape during the third quarter, fueled by thematic momentum and outsized ...